-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on United Therapeutics, Lowers Price Target to $350

Benzinga·05/01/2025 18:03:40
Listen to the news
JP Morgan analyst Jessica Fye maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and lowers the price target from $355 to $350.